Home > Insider Trading > Filing (0000898432-19-001253)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1706431	Vir Biotechnology Inc.	VIR	()	AK

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1582681	Alaska Permanent Fund Corp	801 West 10Th Street Suite 302 Juneau AK 99801		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-10-16	2,222,222	$0.00	5,555,556	No	4	C	Indirect	By Yukon Investors, LLC
Common Stock	Acquisiton	2019-10-16	666,667	$0.00	5,555,556	No	4	C	Indirect	By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P
Common Stock	Acquisiton	2019-10-16	1,111,111	$0.00	5,555,556	No	4	C	Indirect	By Yukon Investors, LLC
Common Stock	Acquisiton	2019-10-16	55,556	$0.00	5,555,556	No	4	C	Indirect	By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P
Common Stock	Acquisiton	2019-10-16	1,500,000	$20.00	5,555,556	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Yukon Investors, LLC
No	4	C	Indirect	By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P
No	4	C	Indirect	By Yukon Investors, LLC
No	4	C	Indirect	By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 convertible preferred stock	Disposition	2019-10-16	2,222,222	$0.00	2,222,222	$0.00
Common Stock	Series A-1 convertible preferred stock	Disposition	2019-10-16	666,667	$0.00	666,667	$0.00
Common Stock	Series B convertible preferred stock	Disposition	2019-01-16	1,111,111	$0.00	1,111,111	$0.00
Common Stock	Series B convertible preferred stock	Disposition	2019-10-16	55,556	$0.00	55,556	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above.